No Data
No Data
HSBC Adjusts Price Target on CVS Health to $61 From $62
Barclays Adjusts Price Target on CVS Health to $63 From $65
Analysts' Opinions Are Mixed on These Healthcare Stocks: CVS Health (CVS), Insulet (PODD) and Artivion (AORT)
CVS Health (CVS) Receives a Rating Update From a Top Analyst
Perrigo Recalls 16,500 Cans of Baby Formula Due to Elevated Vitamin D Levels
CVS Health Corporation (NYSE:CVS) Just Released Its Second-Quarter Earnings: Here's What Analysts Think